Oral bioavailability in pigs of a miconazole/Hydroxypropyl-γ-cyclodextrin/ L-tataric acid inclusion complex produced by supercritical carbon dioxide processing
Journal Title: The AAPS Journal - Year 2005, Vol 7, Issue 1
Abstract
The objective of this study was to determine the pharmacokinetic parameters of miconazole after oral administration of a miconazole/hydroxypropyl-γ-cyclodextrin(HPγCD)/ L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. The pharmacokinetics of the miconazole ternary complex (CPLX), of the corresponding physical mixture (PHYS), and of miconazole alone (MICO) were compared after oral administration. Six mixed-breed pigs received each formulation as a single dose (10 mg miconazole/kg) in a crossover design. Miconazole plasma concentrations were determined by a high-performance liquid chromatography method. Preliminary in vitro dissolution data showed that CPLX exhibits a faster and higher dissolution rate than either PHYS or MICO. Following CPLX oral administration, mean area under the plasma concentration curve (AUC0−∞) for miconazole was 95.0±55.8 μg/min/mL, with the peak plasma concentration (Cmax 0.59±0.39 μg/mL) at 19.30 minutes. The AUC0−∞ and Cmax values were significantly higher than those after oral administration of PHYS (AUC0−∞ 38.5±12.7 μg/min/mL and Cmax 0.24±0.08 μg/mL;P<.1) and of MICO (AUC0−∞ 24.1±14.0 μg/min/mL and Cmax 0.1±0.05 μg/mL;P<.1). There were also significant differences between PHYS and MICO (P<.1). The results of the study indicate that CPLX shows improved dissolution properties and a higher relative oral bioavailability compared with PHYS and MICO.
Authors and Affiliations
Valéry Barillaro, Brigitte Evrard, Luc Delattre, Géraldine Piel
Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model
The online version of this article (doi:10.1208/s12248-015-9792-y) contains supplementary material, which is available to authorized users.
Issues and Challenges of Subvisible and Submicron Particulate Analysis in Protein Solutions
The online version of this article (doi:10.1208/s12248-012-9335-8) contains supplementary material, which is available to authorized users.
Pharmacokinetic model of target-mediated disposition of thrombopoietin
Thrombopoietin, TPO, a 353 amino acid cytokine, is a primary regulator of platelet production that was cloned recently. A target-mediated (platelet receptors) pharmacokinetic model was developed to characterize the dispo...
Protein binding predictions in infants
Plasma binding protein levels are lower in the newborn than in the adult and gradually increase with age. At birth, human serum albumin (HSA) concentrations are close to adult levels (75%–80%), while alpha 1-acid...
Pharmacokinetic and Pharmacodynamic Modeling of a Monoclonal Antibody Antagonist of Glucagon Receptor in Male ob/ob Mice
Elevated basal concentrations of glucagon and reduced postprandial glucagon suppression are partly responsible for the increased hepatic glucose production seen in type 2 diabetic patients. Recently, it was demonstrated...